| Code | 41221 | ||||||||||
| MA number | EU/1/97/051/012 | ||||||||||
| Product Form: | tbl 100(10x10)x0,35 mg | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Boehringer Ingelheim International GmbH, Germany | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 26.10.1999 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 14.03.2019 |
